Invention Grant
US07674578B2 Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy
有权
使用sIP-10评估HCV清除率和/或对干扰素治疗的反应的方法
- Patent Title: Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy
- Patent Title (中): 使用sIP-10评估HCV清除率和/或对干扰素治疗的反应的方法
-
Application No.: US11855238Application Date: 2007-09-14
-
Publication No.: US07674578B2Publication Date: 2010-03-09
- Inventor: Matthew Albert , Jeremie Decalf , Stanislas Pol , Arnaud Fontanet , Mostafa Mohamed
- Applicant: Matthew Albert , Jeremie Decalf , Stanislas Pol , Arnaud Fontanet , Mostafa Mohamed
- Applicant Address: FR Paris
- Assignee: Institut Pasteur
- Current Assignee: Institut Pasteur
- Current Assignee Address: FR Paris
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Main IPC: C12Q1/00
- IPC: C12Q1/00 ; G01N33/53
Abstract:
The present invention relates to methods for evaluating and predicting clinical outcomes in patients by measuring levels of sIP-10 protein expression as well as therapies using sIP-10 and its fragments.
Public/Granted literature
- US20080119388A1 METHODS OF USING sIP-10 TO ASSESS HCV CLEARANCE AND/OR RESPONSE TO INTERFERON THERAPY Public/Granted day:2008-05-22
Information query
